Novel Insights into Circular RNAs in Metastasis in Breast Cancer: An Update

Paola Zepeda-Enríquez1, Macrina B Silva-Cázares2, César López-Camarillo1

  • 1Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, CDMX 03100, Mexico.

Non-Coding RNA
|September 22, 2023
PubMed

Insights

Circular RNAs (circRNAs) play key roles in aggressive triple-negative breast cancer (TNBC) by influencing cell growth and metastasis. Understanding circRNAs offers potential for new TNBC diagnostic and therapeutic strategies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are non-coding RNA molecules with aberrant expression in human cancers, forming tumor-specific gene signatures.
  • Triple-negative breast cancer (TNBC) is an aggressive subtype with poor prognosis, and research on circRNAs in TNBC is emerging.
  • circRNAs function as regulators of gene expression through various mechanisms, including microRNA sponging and protein scaffolding.

Purpose of the Study:

  • To review current knowledge on circRNA biogenesis and functions.
  • To summarize recent findings on the roles of circRNAs in TNBC development, progression, and therapeutic resistance.
  • To discuss the involvement of exosomes in circRNA transport in TNBC.

Main Methods:

  • Literature review of circRNA research in cancer, with a focus on TNBC.
  • Analysis of existing studies on circRNA functions, biogenesis, and roles in TNBC.
  • Synthesis of information on exosome-mediated circRNA transport in TNBC.

Main Results:

  • circRNAs are implicated in critical TNBC processes like proliferation, invasion, metastasis, and chemoresistance.
  • circRNAs show potential as prognostic biomarkers and therapeutic targets for TNBC.
  • Exosomes play a significant role in the intercellular transport and export of circRNAs in TNBC.

Conclusions:

  • circRNAs are pivotal in TNBC pathogenesis and progression.
  • Further understanding of circRNA functions in metastasis and therapy response is crucial for developing novel TNBC treatments.
  • circRNAs represent promising targets for future TNBC therapeutic strategies.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K